Oncotarget

Research Papers:

Inhibition of melanocortin 1 receptor slows melanoma growth, reduces tumor heterogeneity and increases survival

Rita G. Kansal _, Matthew S. McCravy, Jacob H. Basham, Joshua A. Earl, Stacy L. McMurray, Chelsey J. Starner, Michael A. Whitt and Lorraine M. Albritton

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:26331-26345. https://doi.org/10.18632/oncotarget.8372

Metrics: PDF 1620 views  |   HTML 2208 views  |   ?  


Abstract

Rita G. Kansal1, Matthew S. McCravy1, Jacob H. Basham1, Joshua A. Earl1, Stacy L. McMurray1, Chelsey J. Starner1, Michael A. Whitt1,*, Lorraine M. Albritton1,*

1Department of Microbiology, Immunology and Biochemistry, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA

*These authors have contributed equally to this work

Correspondence to:

Lorraine M. Albritton, e-mail: [email protected]

Michael A. Whitt, e-mail: [email protected]

Keywords: melanoma, MC1R, agouti, B16-F10, GFP

Received: January 04, 2016    Accepted: March 14, 2016    Published: March 25, 2016

ABSTRACT

Melanoma risk is increased in patients with mutations of melanocortin 1 receptor (MC1R) yet the basis for the increased risk remains unknown. Here we report in vivo evidence supporting a critical role for MC1R in regulating melanoma tumor growth and determining overall survival time. Inhibition of MC1R by its physiologically relevant competitive inhibitor, agouti signaling protein (ASIP), reduced melanin synthesis and morphological heterogeneity in murine B16-F10 melanoma cells. In the lungs of syngeneic C57BL/6 mice, mCherry-marked, ASIP-secreting lung tumors inhibited MC1R on neighboring tumors lacking ASIP in a dose dependent manner as evidenced by a proportional loss of pigment in tumors from mice injected with 1:1, 3:1 and 4:1 mixtures of parental B16-F10 to ASIP-expressing tumor cells. ASIP-expressing B16-F10 cells formed poorly pigmented tumors in vivo that correlated with a 20% longer median survival than those bearing parental B16-F10 tumors (p=0.0005). Mice injected with 1:1 mixtures also showed survival benefit (p=0.0054), whereas injection of a 4:1 mixture showed no significant difference in survival. The longer survival time of mice bearing ASIP-expressing tumors correlated with a significantly slower growth rate than parental B16-F10 tumors as judged by quantification of numbers of tumors and total tumor load (p=0.0325), as well as a more homogeneous size and morphology of ASIP-expressing lung tumors. We conclude that MC1R plays an important role in regulating melanoma growth and morphology. Persistent inhibition of MC1R provided a significant survival advantage resulting in part from slower tumor growth, establishing MC1R as a compelling new molecular target for metastatic melanoma.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8372